Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTA-004 in Symptomatic Knee Osteoarthritis
NCT02740231Phase 3Completed
- Sponsor
- BioSenic
- Start
- Feb 2016
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 3 trial of JTA-004 in knee osteoarthritis (OA), sponsored by BioSenic. Started Feb 2016; status: completed.
02
Drugs
JTA-004
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02740231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740231.